All Stories

  1. Management of children and adults with all stages of nodular lymphocyte predominant Hodgkin lymphoma — All St AGE s : A consensus‐based position paper fro...

    Article • British Journal of Haematology, April 2022, Wiley

    Ananth Shankar

  2. Practice patterns for the management of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL): an international survey by the Global NLPHL One Working Group (GLOW)

    Article • Leukemia & Lymphoma, March 2022, Taylor & Francis

    Ananth Shankar

  3. Treatment outcome with a selective RET tyrosine kinase inhibitor selpercatinib in children with multiple endocrine neoplasia type 2 and advanced medullary thyroid carcinoma

    Article • European Journal of Cancer, November 2021, Elsevier

    Ananth Shankar

  4. Renal protection during 177lutetium DOTATATE molecular radiotherapy in children: a proposal for safe amino acid infusional volume during peptide receptor radionuclide therapy

    Article • Nuclear Medicine Communications, October 2021, Wolters Kluwer Health

    Ananth Shankar

  5. Neuroblastoma-associated Renal Cell Carcinoma: A Case Report and Review of the Literature

    Article • Journal of Pediatric Hematology/Oncology, July 2021, Wolters Kluwer Health

    Ananth Shankar

  6. Hybrid PET–MRI Imaging in Paediatric and TYA Brain Tumours: Clinical Applications and Challenges

    Article • Journal of Personalized Medicine, November 2020, MDPI AG

    Ananth Shankar

  7. Preferred place of death in paediatric, teenage and young adult haemato-oncology patients: a retrospective review

    Article • BMJ Supportive & Palliative Care, March 2020, BMJ

    Ananth Shankar

  8. Cabergoline-related impulse control disorder in an adolescent with a giant prolactinoma

    Article • Clinical Endocrinology, April 2017, Wiley

    Ananth Shankar, Marta Korbonits

  9. Variant histology nodular lymphocyte predominant Hodgkin lymphoma - a route to transformation?

    Article • British Journal of Haematology, April 2017, Wiley

    Ananth Shankar

  10. Advanced stage nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents: clinical characteristics and treatment outcome - a report from the SFCE & CCLG groups

    Article • British Journal of Haematology, February 2017, Wiley

    Ananth Shankar

  11. Relapsed or poorly responsive nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents - a report from the United Kingdom's Children's Cancer and Leukaemia Study Group

    Article • British Journal of Haematology, March 2016, Wiley

    Ananth Shankar

  12. Childhood and Adolescent nodular lymphocyte predominant Hodgkin lymphoma - A review of clinical outcome based on the histological variants

    Article • British Journal of Haematology, June 2015, Wiley

    Ananth Shankar

  13. Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma - results of the UK HD3 relapse treatment strategy

    Article • British Journal of Haematology, February 2014, Wiley

    Ananth Shankar

  14. Dynamic contrast-enhanced MRI improves accuracy for detecting focal splenic involvement in children and adolescents with Hodgkin disease

    Article • Pediatric Radiology, February 2013, Springer Science + Business Media

    Ananth Shankar

  15. Nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents - a comprehensive review of biology, clinical course and treatment options

    Article • British Journal of Haematology, September 2012, Wiley

    Ananth Shankar

  16. Treatment outcome after low intensity chemotherapy [CVP] in children and adolescents with early stage nodular lymphocyte predominant Hodgkin’s lymphoma – An Anglo-French collaborative report

    Article • European Journal of Cancer, July 2012, Elsevier

    Ananth Shankar

  17. Clinical outcome in children and adolescents with Hodgkin lymphoma after treatment with chemotherapy alone – The results of the United Kingdom HD3 national cohort trial

    Article • European Journal of Cancer, January 2012, Elsevier

    Ananth Shankar

  18. Outcome of children with nodular lymphocyte predominant Hodgkin lymphoma - a Children's Cancer and Leukaemia Group report

    Article • British Journal of Haematology, September 2007, Wiley

    Ananth Shankar

  19. Hodgkin’s lymphoma in children aged 5 years or less – The United Kingdom experience

    Article • European Journal of Cancer, June 2007, Elsevier

    Ananth Shankar

  20. Resection alone in 58 children with limited stage, lymphocyte-predominant Hodgkin lymphoma–experience from the European network group on pediatric Hodgkin lymphoma

    Article • Cancer, January 2007, Wiley

    Ananth Shankar

  21. Outcome After Autologous Hemopoietic Stem Cell Transplantation in Relapsed or Refractory Childhood Hodgkin Disease

    Article • Journal of Pediatric Hematology/Oncology, November 2004, Wolters Kluwer Health

    Ananth Shankar

  22. Outcome after relapse in an unselected cohort of children and adolescents with Ewing sarcoma

    Article • Medical and Pediatric Oncology, January 2003, Wiley

    Ananth Shankar

  23. Local therapy and other factors influencing site of relapse in patients with localised Ewing's sarcoma

    Article • European Journal of Cancer, November 1999, Elsevier

    Ananth Shankar

  24. A limited role for VEEP (vincristine, etoposide, epirubicin, prednisolone) chemotherapy in childhood Hodgkin’s disease

    Article • European Journal of Cancer, December 1998, Elsevier

    Ananth Shankar

  25. High-dose busulphan/melphalan with autologous stem cell rescue in Ewing’s sarcoma

    Article • British Journal of Pharmacology, November 1997, Springer Science + Business Media

    Ananth Shankar

  26. Does histology influence outcome in childhood Hodgkin's disease? Results from the United Kingdom Children's Cancer Study Group.

    Article • Journal of Clinical Oncology, July 1997, American Society of Clinical Oncology (ASCO)

    Ananth Shankar